合計 50 件の最近のインサイダー取引記録が記録されています Amylyx Pharmaceuticals, Inc. (AMLX), 内訳は 17 件の買い および 31 件の売り. インサイダー買い総額は $19.97M インサイダー売り総額は $6.08M.
最近活動のある主要インサイダーには Frates James M, Bedrosian Camille L, Klee Justin B.. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — AMLX
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2026-03-05 |
Frates James M |
Chief Financial Officer |
RSU 付与（制限付株式） |
143,985 |
$14.10 |
$2.03M |
143,985 |
| 2026-03-05 |
Bedrosian Camille L |
Chief Medical Officer |
RSU 付与（制限付株式） |
143,985 |
$14.10 |
$2.03M |
143,985 |
| 2026-03-05 |
Klee Justin B. |
Co-chief Executive Officer |
RSU 付与（制限付株式） |
373,295 |
$14.10 |
$5.26M |
373,295 |
| 2026-03-05 |
Cohen Joshua B |
Co-chief Executive Officer |
RSU 付与（制限付株式） |
373,295 |
$14.10 |
$5.26M |
373,295 |
| 2026-03-05 |
Mazzariello Gina |
Chief Legal Officer |
RSU 付与（制限付株式） |
111,990 |
$14.10 |
$1.58M |
111,990 |
| 2026-03-02 |
Frates James M |
Chief Financial Officer |
情報に基づく売り |
7,909 |
$14.52 |
$114.85K |
165,638 |
| 2026-03-02 |
Bedrosian Camille L |
Chief Medical Officer |
情報に基づく売り |
6,461 |
$14.58 |
$94.21K |
169,295 |
| 2026-03-02 |
Klee Justin B. |
Co-chief Executive Officer |
情報に基づく売り |
29,282 |
$14.47 |
$423.76K |
3,334,616 |
| 2026-03-02 |
Cohen Joshua B |
Co-chief Executive Officer |
情報に基づく売り |
29,282 |
$14.48 |
$424.12K |
3,334,683 |
| 2026-03-02 |
Mazzariello Gina |
Chief Legal Officer |
情報に基づく売り |
6,844 |
$14.52 |
$99.38K |
134,430 |
| 2026-02-23 |
Mazzariello Gina |
Chief Legal Officer |
情報に基づく売り |
3,419 |
$14.14 |
$48.35K |
141,274 |
| 2026-02-02 |
Frates James M |
Chief Financial Officer |
情報に基づく売り |
3,557 |
$14.65 |
$52.1K |
173,547 |
| 2026-02-02 |
Klee Justin B. |
Co-chief Executive Officer |
情報に基づく売り |
15,500 |
$14.69 |
$227.62K |
3,363,898 |
| 2026-02-02 |
Cohen Joshua B |
Co-chief Executive Officer |
情報に基づく売り |
15,500 |
$14.68 |
$227.59K |
3,363,965 |
| 2026-02-02 |
Mazzariello Gina |
Chief Legal Officer |
情報に基づく売り |
3,448 |
$14.65 |
$50.52K |
144,693 |
| 2026-01-16 |
Klee Justin B. |
Co-chief Executive Officer |
オプション行使（売却） |
2,847 |
$7.57 |
$21.55K |
- |
| 2026-01-16 |
Cohen Joshua B |
Co-chief Executive Officer |
オプション行使（売却） |
2,818 |
$7.57 |
$21.33K |
- |
| 2026-01-15 |
Klee Justin B. |
Co-chief Executive Officer |
オプション行使（売却） |
197,153 |
$7.57 |
$1.49M |
2,847 |
| 2026-01-15 |
Cohen Joshua B |
Co-chief Executive Officer |
オプション行使（売却） |
197,182 |
$7.57 |
$1.49M |
2,818 |
| 2026-01-12 |
Milne George M Jr |
Director |
贈与（送付） |
17,780 |
- |
- |
812,881 |
| 2026-01-06 |
Frates James M |
Chief Financial Officer |
情報に基づく売り |
3,326 |
$11.11 |
$36.95K |
177,104 |
| 2026-01-06 |
Klee Justin B. |
Co-chief Executive Officer |
情報に基づく売り |
7,715 |
$11.09 |
$85.59K |
3,317,586 |
| 2026-01-06 |
Cohen Joshua B |
Co-chief Executive Officer |
情報に基づく売り |
7,715 |
$11.09 |
$85.6K |
3,317,632 |
| 2025-12-23 |
Firestone Karen |
Director |
情報に基づく買い |
8,100 |
$12.45 |
$100.85K |
63,100 |
| 2025-12-01 |
Bedrosian Camille L |
Chief Medical Officer |
情報に基づく売り |
6,580 |
$14.35 |
$94.42K |
175,756 |
| 2025-09-30 |
Frates James M |
Chief Financial Officer |
情報に基づく売り |
10,558 |
$14.65 |
$154.65K |
280,430 |
| 2025-09-30 |
Bedrosian Camille L |
Chief Medical Officer |
情報に基づく売り |
12,039 |
$14.58 |
$175.52K |
182,336 |
| 2025-09-30 |
Klee Justin B. |
Co-chief Executive Officer |
情報に基づく売り |
200 |
$15.01 |
$3K |
3,325,301 |
| 2025-09-30 |
Cohen Joshua B |
Co-chief Executive Officer |
情報に基づく売り |
200 |
$15.00 |
$3K |
3,325,347 |
| 2025-09-30 |
Mazzariello Gina |
Chief Legal Officer |
情報に基づく売り |
8,828 |
$14.58 |
$128.67K |
148,141 |
| 2025-08-13 |
Mazzariello Gina |
Chief Legal Officer |
情報に基づく売り |
15,000 |
$8.34 |
$125.05K |
156,969 |
| 2025-08-12 |
Mazzariello Gina |
Chief Legal Officer |
情報に基づく売り |
15,000 |
$8.07 |
$121.1K |
171,969 |
| 2025-06-05 |
Milne George M Jr |
Director |
RSU 付与（制限付株式） |
25,000 |
$5.05 |
$126.25K |
25,000 |
| 2025-06-05 |
Quimi Daphne |
Director |
RSU 付与（制限付株式） |
25,000 |
$5.05 |
$126.25K |
25,000 |
| 2025-06-05 |
Fonteyne Paul R. |
Director |
RSU 付与（制限付株式） |
25,000 |
$5.05 |
$126.25K |
25,000 |
| 2025-06-05 |
Firestone Karen |
Director |
RSU 付与（制限付株式） |
25,000 |
$5.05 |
$126.25K |
25,000 |
| 2025-06-05 |
Zeiher Bernhardt G |
Director |
RSU 付与（制限付株式） |
25,000 |
$5.05 |
$126.25K |
25,000 |
| 2025-05-22 |
Mazzariello Gina |
Chief Legal Officer |
贈与（送付） |
1,000 |
- |
- |
186,969 |
| 2025-03-31 |
Frates James M |
Chief Financial Officer |
情報に基づく売り |
10,896 |
$3.47 |
$37.81K |
290,988 |
| 2025-03-31 |
Bedrosian Camille L |
Chief Medical Officer |
情報に基づく売り |
12,425 |
$3.47 |
$43.08K |
194,375 |
| 2025-03-31 |
Klee Justin B. |
Co-chief Executive Officer |
情報に基づく売り |
21,490 |
$3.46 |
$74.45K |
3,355,276 |
| 2025-03-31 |
Cohen Joshua B |
Co-chief Executive Officer |
情報に基づく売り |
21,490 |
$3.47 |
$74.48K |
3,355,280 |
| 2025-03-31 |
Mazzariello Gina |
Chief Legal Officer |
情報に基づく売り |
9,192 |
$3.48 |
$31.95K |
187,969 |
| 2025-03-20 |
Zeiher Bernhardt G |
Director |
情報に基づく買い |
10,000 |
$3.70 |
$37.01K |
10,000 |
| 2025-03-06 |
Frates James M |
Chief Financial Officer |
RSU 付与（制限付株式） |
102,630 |
$3.61 |
$370.49K |
102,630 |
| 2025-03-06 |
Bedrosian Camille L |
Chief Medical Officer |
RSU 付与（制限付株式） |
102,630 |
$3.61 |
$370.49K |
102,630 |
| 2025-03-06 |
Klee Justin B. |
Co-chief Executive Officer |
RSU 付与（制限付株式） |
270,177 |
$3.61 |
$975.34K |
270,177 |
| 2025-03-06 |
Cohen Joshua B |
Co-chief Executive Officer |
RSU 付与（制限付株式） |
270,177 |
$3.61 |
$975.34K |
270,177 |
| 2025-03-06 |
Mazzariello Gina |
Chief Legal Officer |
RSU 付与（制限付株式） |
95,777 |
$3.61 |
$345.75K |
95,777 |
| 2025-03-03 |
Klee Justin B. |
Co-chief Executive Officer |
情報に基づく売り |
4,595 |
$3.15 |
$14.48K |
3,196,648 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
